Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Yuehua Pharmaceutical is a pharmaceutical manufacturing company based in Xi'an, China, specializing in the production of anti-infective medications. The company's core business revolves around the development and commercialization of generic small molecule drugs, particularly cephalosporin and macrolide antibiotics. Its product line includes Cefaclor, Cefixime, and Roxithromycin, which are distributed across the Chinese domestic market for treating respiratory and urinary tract infections. Xi'an Yuehua maintains GMP-certified production lines for various oral dosage forms, including capsules, tablets, and granules. The firm plays a significant role in the regional pharmaceutical supply chain in Shaanxi Province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Yuehua Pharmaceutical.